In vivo selection of bioprocessable biopharmaceuticals

Summary

In vivo selection of bioprocessable biopharmaceuticals is a research grant^[1].

Key Facts

• In vivo selection of bioprocessable biopharmaceuticals is in the country of United Kingdom^[2].
• In vivo selection of bioprocessable biopharmaceuticals's instance of is recorded as research grant^[3].
• In vivo selection of bioprocessable biopharmaceuticals's instance of is recorded as science project^[4].
• In vivo selection of bioprocessable biopharmaceuticals's location is recorded as University of Leeds^[5].
• In vivo selection of bioprocessable biopharmaceuticals's start time is recorded as +2015-01-06T00:00:00Z^[6].
• In vivo selection of bioprocessable biopharmaceuticals's end time is recorded as +2016-05-31T00:00:00Z^[7].
• In vivo selection of bioprocessable biopharmaceuticals's participant is recorded as David J. Brockwell^[8].
• In vivo selection of bioprocessable biopharmaceuticals's participant is recorded as Astbury Centre for Structural Molecular Biology^[9].
• In vivo selection of bioprocessable biopharmaceuticals's participant is recorded as Sheena Radford^[10].
• In vivo selection of bioprocessable biopharmaceuticals's participant is recorded as AstraZeneca (United States)^[11].
• In vivo selection of bioprocessable biopharmaceuticals's sponsor is recorded as Biotechnology and Biological Sciences Research Council^[12].
• In vivo selection of bioprocessable biopharmaceuticals's sponsor is recorded as Engineering and Physical Sciences Research Council^[13].
• In vivo selection of bioprocessable biopharmaceuticals's official name is recorded as In vivo selection of bioprocessable biopharmaceuticals^[14].
• In vivo selection of bioprocessable biopharmaceuticals's budget is recorded as {'unit': 'http://www.wikidata.org/entity/Q25224', 'amount': '+113378'}^[15].
• In vivo selection of bioprocessable biopharmaceuticals's Gateway to Research Project ID is recorded as BB/M01259X/1^[16].